WANBURY
Back to Income Statement
|
WANBURY Last 5 Year Profit After Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹31 Cr | ₹56 Cr | ₹-10 Cr | ₹81 Cr | ₹-13 Cr |
What is the latest Profit After Tax of WANBURY ?
| Year | Profit After Tax |
|---|---|
| Mar2025 | ₹31 Cr |
| Mar2024 | ₹56 Cr |
| Mar2023 | ₹-10 Cr |
| Mar2022 | ₹81 Cr |
| Mar2021 | ₹-13 Cr |
How is Profit After Tax of WANBURY Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹31 Cr | -45.44 | |
| Mar2024 | ₹56 Cr | Positive | |
| Mar2023 | ₹-10 Cr | Negative | |
| Mar2022 | ₹81 Cr | Positive | |
| Mar2021 | ₹-13 Cr | - | |
Compare Profit After Tax of peers of WANBURY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WANBURY | ₹848.1 Cr | -4.4% | 12.4% | 33.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,777.0 Cr | -0.8% | 7.4% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,931.0 Cr | -1.5% | 5.7% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,330.0 Cr | -1.8% | 8.8% | 44.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,593.0 Cr | -1.2% | 9.2% | 14.9% | Stock Analytics | |
| CIPLA | ₹107,112.0 Cr | -2.5% | 0.1% | -7.6% | Stock Analytics | |
WANBURY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WANBURY | -4.4% |
12.4% |
33.4% |
| SENSEX | -3.8% |
-2% |
6.3% |
You may also like the below Video Courses